Concepts (211)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Selenoprotein P | 7 | 2015 | 50 | 2.230 |
Why?
|
| Methamphetamine | 4 | 2021 | 155 | 1.350 |
Why?
|
| Selenoproteins | 5 | 2017 | 151 | 1.340 |
Why?
|
| Brain | 6 | 2021 | 1268 | 0.930 |
Why?
|
| Selenium | 6 | 2014 | 144 | 0.760 |
Why?
|
| Alzheimer Disease | 3 | 2015 | 881 | 0.730 |
Why?
|
| Hippocampus | 6 | 2014 | 546 | 0.680 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2005 | 131 | 0.660 |
Why?
|
| Glutathione Peroxidase | 3 | 2013 | 109 | 0.580 |
Why?
|
| Synaptic Transmission | 5 | 2013 | 141 | 0.560 |
Why?
|
| Membrane Proteins | 3 | 2017 | 486 | 0.550 |
Why?
|
| tau Proteins | 1 | 2017 | 161 | 0.540 |
Why?
|
| Central Nervous System Stimulants | 2 | 2017 | 165 | 0.540 |
Why?
|
| Choroid Plexus | 1 | 2015 | 6 | 0.530 |
Why?
|
| Alternative Splicing | 2 | 2012 | 82 | 0.500 |
Why?
|
| Neuronal Plasticity | 4 | 2014 | 102 | 0.490 |
Why?
|
| Brain Diseases | 1 | 2014 | 33 | 0.490 |
Why?
|
| Sodium Selenite | 1 | 2013 | 4 | 0.470 |
Why?
|
| RNA, Untranslated | 1 | 2012 | 42 | 0.440 |
Why?
|
| Neurons | 5 | 2013 | 1130 | 0.430 |
Why?
|
| Oxidative Stress | 5 | 2013 | 874 | 0.430 |
Why?
|
| Ethanol | 2 | 2005 | 188 | 0.430 |
Why?
|
| Putamen | 1 | 2012 | 15 | 0.420 |
Why?
|
| Substantia Nigra | 1 | 2012 | 41 | 0.420 |
Why?
|
| Calcium | 3 | 2014 | 445 | 0.410 |
Why?
|
| Neocortex | 3 | 2008 | 26 | 0.370 |
Why?
|
| Parkinson Disease | 1 | 2012 | 167 | 0.370 |
Why?
|
| Disease | 1 | 2009 | 18 | 0.360 |
Why?
|
| Nucleus Accumbens | 2 | 2021 | 80 | 0.350 |
Why?
|
| Animals | 21 | 2021 | 14307 | 0.340 |
Why?
|
| Dopamine | 2 | 2021 | 232 | 0.320 |
Why?
|
| Aged, 80 and over | 4 | 2017 | 2333 | 0.300 |
Why?
|
| RNA, Small Interfering | 3 | 2017 | 391 | 0.300 |
Why?
|
| Long-Term Potentiation | 3 | 2002 | 99 | 0.300 |
Why?
|
| Cerebral Cortex | 1 | 2008 | 274 | 0.290 |
Why?
|
| Pituitary Gland, Anterior | 1 | 2006 | 10 | 0.290 |
Why?
|
| Cell Line, Tumor | 6 | 2017 | 2128 | 0.290 |
Why?
|
| Tilapia | 1 | 2006 | 7 | 0.290 |
Why?
|
| Receptors, Glutamate | 1 | 2006 | 26 | 0.290 |
Why?
|
| Prolactin | 1 | 2006 | 59 | 0.290 |
Why?
|
| Blotting, Western | 4 | 2015 | 834 | 0.290 |
Why?
|
| Maternal Behavior | 1 | 2005 | 22 | 0.280 |
Why?
|
| Social Isolation | 1 | 2005 | 27 | 0.280 |
Why?
|
| Analysis of Variance | 3 | 2017 | 528 | 0.260 |
Why?
|
| Humans | 15 | 2021 | 34853 | 0.240 |
Why?
|
| Pregnancy | 4 | 2021 | 1503 | 0.240 |
Why?
|
| Neuroblastoma | 2 | 2017 | 128 | 0.240 |
Why?
|
| Transfection | 2 | 2017 | 496 | 0.220 |
Why?
|
| Receptors, AMPA | 1 | 2002 | 54 | 0.210 |
Why?
|
| Central Nervous System Depressants | 1 | 2002 | 37 | 0.210 |
Why?
|
| Gene Expression | 3 | 2012 | 639 | 0.210 |
Why?
|
| Rotarod Performance Test | 1 | 2021 | 13 | 0.210 |
Why?
|
| Lyases | 2 | 2012 | 51 | 0.200 |
Why?
|
| Synapses | 1 | 2002 | 173 | 0.190 |
Why?
|
| Rats | 7 | 2013 | 3261 | 0.180 |
Why?
|
| Dizocilpine Maleate | 3 | 2005 | 45 | 0.180 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 859 | 0.170 |
Why?
|
| Behavior, Animal | 3 | 2012 | 304 | 0.170 |
Why?
|
| Brain Chemistry | 2 | 2013 | 134 | 0.160 |
Why?
|
| Rats, Wistar | 4 | 2017 | 202 | 0.160 |
Why?
|
| Mice | 10 | 2014 | 5668 | 0.160 |
Why?
|
| Receptors, sigma | 1 | 2017 | 16 | 0.160 |
Why?
|
| Protein Isoforms | 3 | 2014 | 121 | 0.150 |
Why?
|
| Reactive Oxygen Species | 3 | 2017 | 416 | 0.150 |
Why?
|
| Microscopy, Confocal | 2 | 2008 | 210 | 0.150 |
Why?
|
| Leucine | 1 | 2017 | 28 | 0.150 |
Why?
|
| Proline | 1 | 2017 | 37 | 0.150 |
Why?
|
| Female | 9 | 2021 | 19873 | 0.140 |
Why?
|
| Male | 10 | 2017 | 18870 | 0.140 |
Why?
|
| Animals, Newborn | 3 | 2013 | 323 | 0.140 |
Why?
|
| Dentate Gyrus | 1 | 1995 | 39 | 0.130 |
Why?
|
| Mice, Knockout | 3 | 2012 | 897 | 0.130 |
Why?
|
| Calcium Channels, L-Type | 1 | 2015 | 19 | 0.130 |
Why?
|
| Glucose | 1 | 2017 | 217 | 0.130 |
Why?
|
| Calcium Channel Blockers | 1 | 2015 | 56 | 0.130 |
Why?
|
| Interleukin-6 | 1 | 1995 | 140 | 0.130 |
Why?
|
| Molecular Biology | 1 | 2015 | 44 | 0.130 |
Why?
|
| Presynaptic Terminals | 1 | 2014 | 52 | 0.120 |
Why?
|
| Interleukin-1 | 1 | 1993 | 33 | 0.120 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2013 | 15 | 0.120 |
Why?
|
| Maternal Deprivation | 1 | 2013 | 7 | 0.120 |
Why?
|
| Myelin Proteins | 1 | 2013 | 26 | 0.120 |
Why?
|
| Phosphorylation | 1 | 2017 | 878 | 0.120 |
Why?
|
| Research | 1 | 2015 | 159 | 0.120 |
Why?
|
| Cerebellum | 1 | 2013 | 69 | 0.120 |
Why?
|
| Oncogene Proteins | 1 | 2013 | 18 | 0.120 |
Why?
|
| Cytoprotection | 1 | 2013 | 32 | 0.120 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2013 | 58 | 0.120 |
Why?
|
| Schools, Medical | 1 | 2015 | 192 | 0.110 |
Why?
|
| Untranslated Regions | 1 | 2012 | 6 | 0.110 |
Why?
|
| Ion Transport | 1 | 2012 | 15 | 0.110 |
Why?
|
| RNA Splice Sites | 1 | 2012 | 10 | 0.110 |
Why?
|
| Up-Regulation | 1 | 2015 | 490 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 2 | 2010 | 161 | 0.110 |
Why?
|
| Glutathione | 1 | 2013 | 160 | 0.110 |
Why?
|
| RNA, Messenger | 1 | 2017 | 1152 | 0.110 |
Why?
|
| Mutation | 1 | 2017 | 1023 | 0.110 |
Why?
|
| Stereotaxic Techniques | 1 | 2012 | 20 | 0.110 |
Why?
|
| Universities | 1 | 2015 | 363 | 0.110 |
Why?
|
| Maze Learning | 1 | 2012 | 100 | 0.110 |
Why?
|
| Excitatory Amino Acid Antagonists | 2 | 2002 | 92 | 0.110 |
Why?
|
| Sequence Analysis, RNA | 1 | 2012 | 104 | 0.110 |
Why?
|
| Fear | 1 | 2014 | 234 | 0.100 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2012 | 72 | 0.100 |
Why?
|
| Aged | 2 | 2017 | 6448 | 0.100 |
Why?
|
| alpha-Synuclein | 1 | 2012 | 48 | 0.100 |
Why?
|
| RNA Interference | 1 | 2012 | 225 | 0.100 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 968 | 0.100 |
Why?
|
| Down-Regulation | 1 | 2013 | 420 | 0.100 |
Why?
|
| Excitatory Postsynaptic Potentials | 2 | 2002 | 75 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 984 | 0.090 |
Why?
|
| Cell Survival | 1 | 2013 | 818 | 0.090 |
Why?
|
| Cytosol | 1 | 2010 | 85 | 0.090 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2010 | 126 | 0.090 |
Why?
|
| Mice, Transgenic | 4 | 2014 | 608 | 0.090 |
Why?
|
| Hawaii | 2 | 2015 | 1878 | 0.090 |
Why?
|
| Small-Conductance Calcium-Activated Potassium Channels | 1 | 2008 | 8 | 0.090 |
Why?
|
| Cross-Linking Reagents | 1 | 2008 | 48 | 0.080 |
Why?
|
| Insulin-Secreting Cells | 1 | 2008 | 27 | 0.080 |
Why?
|
| Cell Death | 1 | 2010 | 260 | 0.080 |
Why?
|
| Organ Culture Techniques | 2 | 2014 | 99 | 0.080 |
Why?
|
| Cell Count | 1 | 2008 | 129 | 0.080 |
Why?
|
| Neurofibrillary Tangles | 1 | 2008 | 112 | 0.080 |
Why?
|
| Aging | 1 | 2013 | 639 | 0.080 |
Why?
|
| MicroRNAs | 1 | 2012 | 386 | 0.080 |
Why?
|
| Neuroprotective Agents | 1 | 2010 | 231 | 0.080 |
Why?
|
| Recombinant Proteins | 1 | 2008 | 485 | 0.080 |
Why?
|
| Insulin | 1 | 2008 | 224 | 0.070 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2006 | 9 | 0.070 |
Why?
|
| Radioimmunoassay | 1 | 2006 | 66 | 0.070 |
Why?
|
| Biotransformation | 1 | 2006 | 65 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2010 | 1442 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 3 | 2017 | 1530 | 0.070 |
Why?
|
| Ion Channel Gating | 1 | 2006 | 81 | 0.070 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2006 | 195 | 0.070 |
Why?
|
| Calcium Channels | 1 | 2006 | 72 | 0.070 |
Why?
|
| Adult | 1 | 2021 | 11034 | 0.070 |
Why?
|
| Glutamic Acid | 1 | 2006 | 115 | 0.070 |
Why?
|
| Plant Proteins | 1 | 2004 | 93 | 0.060 |
Why?
|
| Tritium | 1 | 2002 | 48 | 0.050 |
Why?
|
| Radioligand Assay | 1 | 2002 | 61 | 0.050 |
Why?
|
| Motor Activity | 2 | 2017 | 393 | 0.050 |
Why?
|
| Quinoxalines | 1 | 2002 | 27 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 338 | 0.050 |
Why?
|
| Antibodies | 1 | 2002 | 135 | 0.050 |
Why?
|
| Amino Acid Sequence | 2 | 2014 | 1124 | 0.050 |
Why?
|
| Piperazines | 1 | 2002 | 109 | 0.050 |
Why?
|
| Molecular Sequence Data | 2 | 2014 | 1490 | 0.050 |
Why?
|
| Alcoholism | 1 | 2004 | 220 | 0.050 |
Why?
|
| Hyperinsulinism | 2 | 2012 | 17 | 0.050 |
Why?
|
| Age Factors | 2 | 2013 | 1007 | 0.050 |
Why?
|
| Pregnancy Trimester, Third | 1 | 1999 | 10 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2002 | 562 | 0.040 |
Why?
|
| Gestational Age | 1 | 1999 | 190 | 0.040 |
Why?
|
| Vesicular Monoamine Transport Proteins | 1 | 2017 | 6 | 0.040 |
Why?
|
| Tissue Culture Techniques | 1 | 2017 | 32 | 0.040 |
Why?
|
| Dopamine Agents | 1 | 2017 | 24 | 0.040 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2017 | 63 | 0.040 |
Why?
|
| Nervous System | 1 | 1996 | 29 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 1995 | 63 | 0.030 |
Why?
|
| Electric Stimulation | 1 | 1995 | 177 | 0.030 |
Why?
|
| Evoked Potentials | 1 | 1995 | 83 | 0.030 |
Why?
|
| Antioxidants | 1 | 2017 | 386 | 0.030 |
Why?
|
| Tetany | 1 | 1993 | 2 | 0.030 |
Why?
|
| Selenocysteine | 1 | 2014 | 52 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 1999 | 1300 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2014 | 186 | 0.030 |
Why?
|
| Serum Albumin, Bovine | 1 | 1993 | 49 | 0.030 |
Why?
|
| Peroxiredoxins | 1 | 2013 | 10 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2014 | 257 | 0.030 |
Why?
|
| Random Allocation | 1 | 2013 | 139 | 0.030 |
Why?
|
| Endocytosis | 1 | 2014 | 104 | 0.030 |
Why?
|
| Neostriatum | 1 | 2013 | 25 | 0.030 |
Why?
|
| Hot Temperature | 1 | 1993 | 120 | 0.030 |
Why?
|
| Mesencephalon | 1 | 2013 | 41 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 383 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2012 | 7 | 0.030 |
Why?
|
| Ligands | 1 | 2014 | 317 | 0.030 |
Why?
|
| Hypercholesterolemia | 1 | 2012 | 36 | 0.030 |
Why?
|
| Glucose Intolerance | 1 | 2012 | 42 | 0.030 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2012 | 49 | 0.030 |
Why?
|
| Cytokines | 1 | 1996 | 569 | 0.030 |
Why?
|
| Fatty Liver | 1 | 2012 | 56 | 0.030 |
Why?
|
| Leptin | 1 | 2012 | 115 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2012 | 245 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 1681 | 0.020 |
Why?
|
| Oxidants | 1 | 2010 | 43 | 0.020 |
Why?
|
| Luminescent Proteins | 1 | 2010 | 74 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2010 | 72 | 0.020 |
Why?
|
| Apamin | 1 | 2008 | 8 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2010 | 181 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1993 | 1534 | 0.020 |
Why?
|
| Sex Factors | 1 | 2012 | 859 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2010 | 407 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2008 | 85 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2008 | 213 | 0.020 |
Why?
|
| Astrocytes | 1 | 2010 | 203 | 0.020 |
Why?
|
| Action Potentials | 1 | 2008 | 219 | 0.020 |
Why?
|
| Cell Line | 1 | 2010 | 1289 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2008 | 550 | 0.020 |
Why?
|
| Synaptosomal-Associated Protein 25 | 1 | 2004 | 8 | 0.020 |
Why?
|
| Integrases | 1 | 2004 | 27 | 0.020 |
Why?
|
| Gene Targeting | 1 | 2004 | 39 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2004 | 78 | 0.020 |
Why?
|
| Obesity | 1 | 2012 | 965 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2004 | 214 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 298 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2004 | 283 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2004 | 430 | 0.010 |
Why?
|
| Phenotype | 1 | 2004 | 650 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 522 | 0.010 |
Why?
|